Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
47 /100
MEDIUM RISK
Score updated Oct 13, 2026

NMRA — Neumora Therapeutics, Inc. Dilution Risk Tracker

Track NMRA dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track NMRA — Get alerts when the score changes →

As of October 13, 2026, Neumora Therapeutics, Inc. (NMRA) has a DilutionWatch DilutionScore of 47/100, rated MEDIUM dilution risk. Neumora Therapeutics, Inc. has a market capitalization of $82.17M, 187.90M shares outstanding, 117 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
42
💰 Cash Runway
65
📊 Float Risk
32
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

⛅
Watch
Minor dilution signals detected
model est. 17%
🔄 Reverse Split model est. 25%
• 52-week low $0.69 has breached $1
• 10 months cash with weak price
💰 Capital Raise model 15%
• Under 12 months cash (10mo)
🔔 Track NMRA — Get forecast alerts →

Market Data

Market Cap$82.17M
Shares Outstanding187.90M
Float104.83M
Cash$159.29M
Debt$112.91M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore47/100DilutionWatch score record
Shares Outstanding187.90MVerified float table or market cache
Public Float104.83MVerified float table or market cache
Market Cap$82.17MMarket data cache
Cash Runway10.5 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 7.

Recent SEC source mix: FORM 4 5, XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 38.0% shares (2026Q1 vs prior)
117 institutional holders · 87.49M shares
#1 PERCEPTIVE ADVISORS LLC 10.21M shares
#2 Siren, L.L.C. 8.50M shares
#3 VANGUARD CAPITAL MANAGEMENT LLC 7.78M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest6.69M
Days to Cover2.7
% of Float6.4%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2026-03-30
xbrl XBRL WARRANT 2025-03-03
Form 4 INSIDER TRANSACTION 2026-08-21
Form 4 INSIDER TRANSACTION 2026-08-21
Form 4 INSIDER TRANSACTION 2026-08-21
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual NMRA Dilution Snapshot

Neumora Therapeutics, Inc. (NMRA) has a DilutionScore of 47/100, rated Medium dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

NMRA's DilutionScore is currently 47/100 (Medium risk), with 1 score change tracked over 89 days. The score improved from 39/100 (Medium risk).

Period Score Risk Level Duration
Aug 22 – Oct 13, 202647/100MEDIUM53 days
Jul 16 – Aug 21, 202639/100MEDIUM36 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

NMRA shares outstanding have increased 0.4% from 182.04M (Apr 2026) to 182.69M (Apr 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
Apr 26, 2026182.69M104.83M▲ 0.26%
Apr 07, 2026182.04M104.56M▲ 16.95%
Apr 01, 2026182.04M89.40M▲ 8.95%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track NMRA Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment NMRA files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking NMRA — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for NMRA
NMRA FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.